Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,935 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
UCHL1 promotes cancer stemness in triple-negative breast cancer.
Tian C, Liu Y, Liu Y, Hu P, Xie S, Guo Y, Wang H, Zhang Z, Du L, Lei B, Wang Y, Xue L, Zhang D, Su J, Zhang X, Zhang R, Chen J, Zhang X, Chen L, Li M, Jia Q, Song J, Liu J. Tian C, et al. Pathol Res Pract. 2022 Dec;240:154235. doi: 10.1016/j.prp.2022.154235. Epub 2022 Nov 21. Pathol Res Pract. 2022. PMID: 36434856
OTX1 regulates tumorigenesis and metastasis in glioma.
Cao B, Liu K, Tian C, He H, He S, Chen H, Zhang X, Liu Y, Wang L, Liu X, Li M, Jia Q, Chai J. Cao B, et al. Among authors: tian c. Pathol Res Pract. 2024 Feb;254:155116. doi: 10.1016/j.prp.2024.155116. Epub 2024 Jan 10. Pathol Res Pract. 2024. PMID: 38218040
A patient with BRAF N581S mutation-positive lung adenocarcinoma demonstrates durable response to combined anlotinib and tislelizumab: A case report and literature review.
Liu Y, Li M, Guo Y, Zhang Z, Du L, Zhang X, Wang Y, Zhang D, Xue L, Lei B, Su J, Zhang R, Chen J, Zhang X, Jia Q, Tian C. Liu Y, et al. Among authors: tian c. Pathol Res Pract. 2024 Jul;259:155371. doi: 10.1016/j.prp.2024.155371. Epub 2024 May 28. Pathol Res Pract. 2024. PMID: 38820929 Review.
Apatinib with etoposide capsules as a third- or further-line therapy for extensive-stage small cell lung cancer: an open-label, multicenter, single-arm phase II trial.
He Z, Zhou H, Wang J, Li D, Zhang X, Wang P, Ma T, Zhang Y, Tian C, Chen Y, Zou M, Han Y, Xu C, Ma S, Wang L, Wu X, Chen G, Wang Q. He Z, et al. Among authors: tian c. Transl Lung Cancer Res. 2021 Feb;10(2):889-899. doi: 10.21037/tlcr-20-1235. Transl Lung Cancer Res. 2021. PMID: 33718030 Free PMC article.
4,935 results